258 related articles for article (PubMed ID: 33074480)
1. Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
Vives-Corrons JL; Krishnevskaya E; Rodriguez IH; Ancochea A
Int J Hematol; 2021 Feb; 113(2):163-174. PubMed ID: 33074480
[TBL] [Abstract][Full Text] [Related]
2. Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants.
Vives-Corrons JL; Krishnevskaya E; Hernández-Rodriguez I; Payán-Pernia S; Sevilla ÁFR; Badell I
Ann Hematol; 2022 Mar; 101(3):549-555. PubMed ID: 34845540
[TBL] [Abstract][Full Text] [Related]
3. Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.
Zaninoni A; Fermo E; Vercellati C; Consonni D; Marcello AP; Zanella A; Cortelezzi A; Barcellini W; Bianchi P
Front Physiol; 2018; 9():451. PubMed ID: 29755372
[TBL] [Abstract][Full Text] [Related]
4. Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders.
Llaudet-Planas E; Vives-Corrons JL; Rizzuto V; Gómez-Ramírez P; Sevilla Navarro J; Coll Sibina MT; García-Bernal M; Ruiz Llobet A; Badell I; Velasco-Puyó P; Dapena JL; Mañú-Pereira MM
Int J Lab Hematol; 2018 Feb; 40(1):94-102. PubMed ID: 29024480
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer.
Da Costa L; Suner L; Galimand J; Bonnel A; Pascreau T; Couque N; Fenneteau O; Mohandas N; ;
Blood Cells Mol Dis; 2016 Jan; 56(1):9-22. PubMed ID: 26603718
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of targeted next-generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience.
Agarwal AM; McMurty V; Clayton AL; Bolia A; Reading NS; Mani C; Patel JL; Rets A
Eur J Haematol; 2023 Jun; 110(6):688-695. PubMed ID: 36825813
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic elevation of the hyperchromic red blood cell subpopulation is associated with decreased red cell deformability.
Deuel JW; Lutz HU; Misselwitz B; Goede JS
Ann Hematol; 2012 Sep; 91(9):1427-34. PubMed ID: 22526368
[TBL] [Abstract][Full Text] [Related]
8. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience.
Lazarova E; Gulbis B; Oirschot BV; van Wijk R
Clin Chem Lab Med; 2017 Mar; 55(3):394-402. PubMed ID: 27559691
[TBL] [Abstract][Full Text] [Related]
9. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
10. Hereditary spherocytosis.
Iolascon A; Avvisati RA; Piscopo C
Transfus Clin Biol; 2010 Sep; 17(3):138-42. PubMed ID: 20655264
[TBL] [Abstract][Full Text] [Related]
11. Advances in understanding the pathogenesis of red cell membrane disorders.
Iolascon A; Andolfo I; Russo R
Br J Haematol; 2019 Oct; 187(1):13-24. PubMed ID: 31364155
[TBL] [Abstract][Full Text] [Related]
12. A Systematic review on diagnostic methods of red cell membrane disorders in Asia.
Silva R; Amarasinghe D; Perera S; Premawardhena A
Int J Lab Hematol; 2022 Apr; 44(2):248-262. PubMed ID: 35068068
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.
Choi HS; Choi Q; Kim JA; Im KO; Park SN; Park Y; Shin HY; Kang HJ; Kook H; Kim SY; Kim SJ; Kim I; Kim JY; Kim H; Park KD; Park KB; Park M; Park SK; Park ES; Park JA; Park JE; Park JK; Baek HJ; Seo JH; Shim YJ; Ahn HS; Yoo KH; Yoon HS; Won YW; Lee KS; Lee KC; Lee MJ; Lee SA; Lee JA; Lee JM; Lee JH; Lee JW; Lim YT; Jung HJ; Chueh HW; Choi EJ; Jung HL; Kim JH; Lee DS;
Orphanet J Rare Dis; 2019 May; 14(1):114. PubMed ID: 31122244
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of the erythrocyte membrane.
Lam SK; Quah TC
J Singapore Paediatr Soc; 1991; 33(3-4):140-8. PubMed ID: 1812330
[TBL] [Abstract][Full Text] [Related]
15. Hereditary red cell membrane disorders and laboratory diagnostic testing.
King MJ; Zanella A
Int J Lab Hematol; 2013 Jun; 35(3):237-43. PubMed ID: 23480868
[TBL] [Abstract][Full Text] [Related]
16. [Application of systematic etiological analysis in final and differential diagnosis of hereditary hemolytic anemia].
Li JY; Gu HH; Zheng SJ; Zha ZS; Hua MX; Jiang JJ; Cai B; Zhou L; Jia Y; Fang CP; Qian BH
Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):512-6. PubMed ID: 27431078
[TBL] [Abstract][Full Text] [Related]
17. Red cell membrane disorders.
Narla J; Mohandas N
Int J Lab Hematol; 2017 May; 39 Suppl 1():47-52. PubMed ID: 28447420
[TBL] [Abstract][Full Text] [Related]
18. Identification of red blood cell membrane defects in a patient with hereditary spherocytosis using next‑generation sequencing technology and matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry.
Şener LT; Aktan M; Albeniz G; Şener A; Üstek D; Albeniz I
Mol Med Rep; 2019 May; 19(5):3912-3922. PubMed ID: 30896804
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and clinical management of red cell membrane disorders.
Kalfa TA
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):331-340. PubMed ID: 34889366
[TBL] [Abstract][Full Text] [Related]
20. A Novel
Jang W; Kim SK; Nahm CH; Choi JW; Kim JJ; Moon Y
Ann Clin Lab Sci; 2021 Jan; 51(1):136-139. PubMed ID: 33653793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
